These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 7523549)
1. A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas. Koop I; Eissele R; Richter S; Patberg H; Meyer F; Mössner J; Arnold R; Koop H Int J Pancreatol; 1994 Jun; 15(3):215-22. PubMed ID: 7523549 [TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini. Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini. Akiyama T; Tachibana I; Otsuki M Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase. Ding XQ; Chen D; Håkanson R Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084 [TBL] [Abstract][Full Text] [Related]
6. Two functionally distinct cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid hydrolysis in isolated rat pancreatic acini. Studies using a new cholecystokinin analog, JMV-180. Matozaki T; Göke B; Tsunoda Y; Rodriguez M; Martinez J; Williams JA J Biol Chem; 1990 Apr; 265(11):6247-54. PubMed ID: 1690723 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini. Akiyama T; Otsuki M Pancreas; 1994 May; 9(3):324-31. PubMed ID: 8022754 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini. Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683 [TBL] [Abstract][Full Text] [Related]
9. Gastrin effects on growth and exocrine secretion in the neonatal rat pancreas. Ballinger A; Ahmed M; Kumar P; Clark M Pancreas; 1997 Apr; 14(3):295-300. PubMed ID: 9094162 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist. Akiyama T; Tachibana I; Hirohata Y; Shirohara H; Yamamoto M; Otsuki M Br J Pharmacol; 1996 Apr; 117(7):1558-64. PubMed ID: 8730754 [TBL] [Abstract][Full Text] [Related]
11. Effect of L364718, a new CCK antagonist, on amylase secretion in isolated rat pancreatic acini. Hosotani R; Chowdhury P; McKay D; Rayford PL Pancreas; 1988; 3(1):95-8. PubMed ID: 2452436 [TBL] [Abstract][Full Text] [Related]
12. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini. Pollo DA; Baldassare JJ; Honda T; Henderson PA; Talkad VD; Gardner JD Biochim Biophys Acta; 1994 Oct; 1224(1):127-38. PubMed ID: 7524684 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological study of gastrin-mediated amylase release in pancreatic acinar cells (AR4-2J). Bertrand V; Bastié MJ; Bigaud C; Pyronnet S; Vaysse N; Pradayrol L Regul Pept; 1994 Dec; 54(2-3):513-25. PubMed ID: 7536336 [TBL] [Abstract][Full Text] [Related]
14. PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist. Höcker M; Hughes J; Fölsch UR; Schmidt WE Eur J Pharmacol; 1993 Sep; 242(1):105-8. PubMed ID: 7901038 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies. Louie DS; Liang JP; Owyang C Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681 [TBL] [Abstract][Full Text] [Related]
17. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for the growth factor action of gastrin. Todisco A; Takeuchi Y; Urumov A; Yamada J; Stepan VM; Yamada T Am J Physiol; 1997 Oct; 273(4):G891-8. PubMed ID: 9357832 [TBL] [Abstract][Full Text] [Related]
19. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin. Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro. Taniguchi H; Yazaki N; Endo T; Nagasaki M Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]